Elisa Contraceptive Tablet (28pcs Box)

Uses of Elisa Contraceptive Pill

• Contraception (Prevent pregnancy)

Administration of Elisa Contraceptive Pill

• Missed Tablets: White placebo tablets can be disregarded. If a pink tablet is missed, take it as soon as remembered, even if it means taking two tablets the next day. Use additional contraception for the next 7 days. If two pink tablets are missed, discontinue and use a barrier method until the next menstruation. Start a new pack from the first day of the next period.
• Missed Periods: If all pills were taken correctly and no vomiting or other medications were involved, continue taking tablets. If two periods are missed, consult your doctor and do not start a new pack until pregnancy is ruled out.
• Delaying a Period: Continue with a new pack after finishing the pink tablets of the current pack, skipping the white tablets. The period can be delayed until the end of the pink tablets in the second pack. Breakthrough bleeding or spotting may occur. Start the next pack after a 4-day interval.
• Vomiting: If vomiting occurs within 3-4 hours of taking a pink tablet, follow the missed tablet instructions. Take an extra active tablet from a backup pack if needed.

Side Effects of Elisa Contraceptive Pill

• Stomach pain
• Headache
• Nausea
• Breast pain
• Weight gain
• Irregular uterine bleeding

Most side effects do not require medical attention and resolve over time. Contact your doctor if side effects persist.

Quick Suggestions:

• Your doctor has prescribed Ethinyl Estradiol + Drospirenone to help you prevent pregnancy.
• It also results in lighter, less painful, and more regular menstrual bleeding.
• It may help reduce the risk of ovarian cancer.
• Take your pill at the same time every day to help you remember to take it.
• You may experience menstrual irregularities such as spotting or bleeding between menstrual periods or missed periods. Consult your doctor if this persists.
• Do not use Ethinyl Estradiol + Drospirenone if you are obese, over 35, smoke, on prolonged bed rest, or have a history of blood clots.
• Stop taking this medicine and inform your doctor immediately if you notice unexplained swelling and pain in your limbs, shortness of breath, chest pain, severe headache, or changes in vision. These could be symptoms of a blood clot in a vein.
• Stop taking Ethinyl Estradiol + Drospirenone and inform your doctor immediately if you notice your skin and whites of the eye turning yellow (jaundice), severe stomach pain, severe depression, or if you think you could be pregnant.

Indication of Elisa Contraceptive Pill

Pharmacology

Elisa contains Ethinylestradiol and Drospirenone. Ethinylestradiol is a synthetic estrogen, and Drospirenone is a synthetic progesterone. These hormones prevent ovulation by inhibiting gonadotropin release. Secondary contraceptive mechanisms include altering cervical mucus to impede sperm penetration and modifying the endometrium to reduce implantation likelihood.

Drospirenone has antimineralocorticoid activity, countering estrogen-related sodium retention. Combined with Ethinylestradiol, Drospirenone improves lipid profiles by increasing high-density lipoprotein (HDL). Drospirenone also has antiandrogenic effects and enhances sex hormone-binding globulin, which binds and inactivates endogenous androgens.

Dosage & Administration of Elisa Contraceptive Pill

1. For maximum contraceptive effectiveness, take the tablets as directed daily at the same time. Start with the first pink tablet from the upper row and continue for 24 consecutive days, followed by the white tablets from days 25 to 28. Withdrawal bleeding typically begins 2-3 days after starting the white tablets. Continue taking white tablets even if menstruation starts. Start the next pack the day after the last white tablet of the previous pack.

• Without prior hormonal contraceptive use: Begin on day 1 of the menstrual cycle with the first pink tablet. No additional contraception is required. Starting on days 2-5 is permissible, but use a barrier method for the first 7 days.
• Switching from another combined hormonal contraceptive: Start with the first pink tablet the day after the last active tablet of the previous contraceptive. If switching from a vaginal ring or patch, start the day of removal.
• Switching from a progestogen-only method: Switch any day from the minipill, or from an implant or IUS on removal day, or from an injection when the next dose is due. Use a barrier method for the first 7 days.
• Post first-trimester abortion: Start immediately, no additional contraception needed.
• Post-delivery or second-trimester abortion: Start 21-28 days after delivery or abortion. Use a barrier method for the first 7 days if starting later.

2. Pediatric Use: Indicated after menarche. No dosage adjustment is needed.

3. Elderly: Not indicated after menopause.

Interaction

Certain drugs may decrease Ethinylestradiol concentrations, causing breakthrough bleeding or reduced contraceptive efficacy. Examples include rifampicin, phenytoin, and some antibiotics. Use a non-hormonal backup contraceptive method when taking these drugs.

Do not use this tablet if you:

• Are pregnant or suspect pregnancy
• Have heart disease or blood clotting disorders
• Suffer from liver disease or jaundice
• Have high blood pressure, migraines, breast lumps, or diabetes with vascular involvement
• Experience unexplained vaginal bleeding
• Have a history of thromboembolic events, liver tumors, pancreatitis with hypertriglyceridemia, severe renal insufficiency, or hypersensitivity to components of this preparation

Pregnancy & Lactation

During pregnancy: Contraindicated. Exclude pregnancy before starting. If pregnancy occurs, discontinue use immediately. Use non-hormonal contraception for three months before attempting to conceive after discontinuation.

During lactation: Combined pills may reduce breast milk quantity and alter composition. Generally not recommended until breastfeeding has ceased. Small amounts of contraceptive steroids may be excreted in milk.

Precautions & Warnings

Evaluate the benefits versus risks for women with circulatory disorders or other risk factors before starting combined oral contraceptives (COCs). Discontinue use if these conditions worsen. Consult your physician if experiencing symptoms.

Storage Conditions:

Store below 30°C, away from light and out of reach of children.